Latest news
China approval for TransThera’s Yochanra - The Pharma LetterThe Pharma Letter · Fri, 07 Aug 2026 19:24:48 GMTChina approves therapy tackling FGFR inhibitor resistance in biliary cancer - FirstWord PharmaFirstWord Pharma · Fri, 07 Aug 2026 13:02:10 GMTYochanra® approved in China as world-first for FGFR inhibitor-resistant cancer - European Pharmaceutical ReviewEuropean Pharmaceutical Review · Fri, 07 Aug 2026 12:25:36 GMTTransThera's resistant biliary cancer drug cleared in China - pharmaphorumpharmaphorum · Fri, 07 Aug 2026 11:50:30 GMTYochanra®, the World's First Innovative Drug to Overcome FGFR Inhibitor Resistance, Makes Its Global Debut in China - Yahoo Finance AustraliaYahoo Finance Australia · Fri, 07 Aug 2026 06:44:00 GMTTransThera Wins First China Approval for Yochanra in Advanced Cholangiocarcinoma - TipRanksTipRanks · Fri, 07 Aug 2026 05:38:49 GMT